Through my work at ZS, I’ve spent a considerable amount of time analyzing revenue leakage. Recently, I contributed to a ZS POV on revenue leakage within the pharmaceutical industry, showcasing public examples of major fraud faced by pharma (and how to mitigate it). I want to highlight a few key points from the article, and … More Revenue Leakage in the Shadows